Table 1.
Variable | MRL_LS | RS_LS | MRL_TS | RS_TS |
GTV | ||||
D95%, cGy | 2402.1 | 2485.0 | 2348.8 | 2437.0 |
Minimum dose, cGy | 2277.5 | 2321.0 | 2186.5 | 2175.0 |
Maximum dose, cGy | 2729.3 | 2759.0 | 2651.8 | 2737.0 |
Conformity index | 0.6 | 0.4 | 0.7 | 0.4 |
Homogeneity index | 1.1 | 1.1 | 1.1 | 1.1 |
R50 | 25.9 | 27.9 | 28.1 | 24.9 |
CTV | ||||
D95%, cGy | 1600.3 | 1601.0 | 1602.8 | 1600.0 |
Conformity index | 0.8 | 0.8 | 0.9 | 0.8 |
Homogeneity index | 1.7 | 1.7 | 1.7 | 1.7 |
Gradient index | 3.7 | 3.8 | 3.4 | 3.4 |
R50 | 4.09 | 4.28 | 4.09 | 3.78 |
Spinal cord | ||||
Maximum dose, cGy | 1042.4 | 1065.0 | 1109.3 | 1032.0 |
V10Gy, cm3 | 0.01 | 0.01 | 0.059 | 0.0 |
Beam-on time, minutes | 13.0 | 8.1 | 12.7 | 7.5 |
Monitor units | 5517.4 | 4869.3 | 5390.3 | 4522.6 |
MRL_LS, Monaco-generated lumbar spine plan; RS_LS, RayStation-generated lumbar spine plan; MRL_TS, Monaco-generated thoracic spine plan; RS_TS, RayStation-generated thoracic spine plan; GTV, gross tumor volume; CTV, clinical target volume